Osteoporosis
Jump to navigation
Jump to search
Moderator:Teemu R (see all) | ||
| ||
Upload data
|
{{#opasnet_base_link:Op_en4523}} | |
This page is a part of Heimtsa incidence database. |
Scope
What is the prevalence of osteoporosis in the general population?
Definition
Rate (age, sex ratio) | Context (population size studied, location, date data taken, end-point measured) | Definition of end-point | Reference | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Spain: ~2 million women with osteoporosis; prevalent in 26.1% of women 50+ | Contains information on fractures and prevalence of osteoporosis across Europe with references for each of the facts | [1] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
7.8 million affected (6.5 million women) | Germany, 2003 | Claims data for patients with osteoporosis (M80, M81) or an osteoporosis-related fracture diagnosis (S22, S32, S42, S52, S72, S82) or treatment with anti-osteoporosis drugs | [2] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
40.8% in women >50 and 17.7% in men >50 | Denmark, 1995-1999 | Based on normal Danish values for BMD, the expected number of subjects aged 50 years + with osteoporosis according to the WHO definition was calculated | [3] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Women, 45-59yrs 5.0% had a BMD <2.5 SD of the mean premenopausal reference value and were thus considered to be osteoporotic. Patients were classified as slow (41.7%), borderline (28.2%), and fast (30.1%) bone losers. By integrating the estimated annual percent bone loss with baseline bone mineral content, 27.6% of the postmenopausal women were identified as at risk of developing osteoporosis at age 65 years. |
n=2286, Italy, risk of osteoporosis | Risk of osteoporosis by combining a baseline distal forearm bone mineral content measurement with an estimation of annual percent bone loss as shown by plasma bone Gla protein, serum alkaline phosphatase, and fasting urinary creatinine-corrected calcium and hydroxyproline | [4] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Sweden, osteoporosis, paper contains other tables and data | WHO criteria | [5] |
Result
{{#opasnet_base_link:Op_en4523}}
See also
Related files
<mfanonymousfilelist></mfanonymousfilelist>
References
- ↑ International Osteoporosis Foundation http://www.iofbonehealth.org/facts-and-statistics.html
- ↑ Epidemiology, treatment and costs of osteoporosis in Germany – the BoneEVA Study; Osteoporosis Int. 2007 v.18(1):77-84
- ↑ Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark; Osteoporos Int. 2005 Feb;16(2):134-41.
- ↑ AGNUSDEI D. CALCAGNO V. CHRISTIANSEN C. CREPALDI G. GENNARI C. MARTINI L. MAZZUOLI G. F. PASQUARELLI V. Prevalence of osteoporosis and prediction of osteoporosis risk in Italian peri- and postmenopausal women : The detection of osteoporosis risk (door) study. Current therapeutic research 1996, vol. 57, no2, pp. 110-122.
- ↑ J. A. Kanis, N. Burlet, C. Cooper, P. D. Delmas, J.-Y. Reginster, F. Borgstrom, R. Rizzoli and on behalf of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Journal Osteoporosis International, Volume 19, Number 4 / April, 2008